Posted in | News | LEDs | Lighting

GLG and LUXIM Sign Strategic Collaboration Deal

Gerard Lighting Group (GLG) and LUXIM have signed a strategic collaboration deal to provide efficient lighting solution in Australia and New Zealand. Under the agreement, GLG will utilize LUXIM's Light Emitting Plasma (LEP) in a range of fixtures for area and street lighting applications. The new lighting products will be introduced shortly in New Zealand and Australia and are expected to provide significant power savings of up to 50%.

The Light Emitting Plasma technology will provide a dynamic industry-changing lighting solution by significantly reducing greenhouse gases in Australia. GLG occupies the largest share of the regions’ lighting market and offers a wide range of popular brands such as Pierlite and Sylvania. The new partnership gives the company a competitive edge, particularly at a time when energy costs are rising rapidly. In New South Wales, the energy costs increased to 22% in 2009. It is estimated that by the year 2013, electricity costs will be 65% higher compared to last year. The collaboration deal will help in bringing down the power consumption costs.

Gerard Lighting Group’s Managing Director, Simon Gerard, informed that the company has been utilizing LEDs for low-lighting applications and through LUXIM's Light Emitting Plasma lamps the company will be able to provide an efficient solution for high-lighting applications. He added that the Light Emitting Plasma technology provides advanced color quality, offers a 50,000 h life, and is an ideal solution for street and other lighting applications.

Tony McGettigan, CEO at LUXIM, commented that the company is happy to collaborate with GLG on this interesting venture, which will provide an efficient lighting solution to the region and will also help in bringing down the power consumption.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.